FVIII:C Deficient Plasma (6 x 1 mL)
In EU: This Product is CE Marked.
Health Canada Licensed.
Deficient plasma for the assay of Factor VIII:C. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FVIII:C, which is brought by the diluted tested plasma, and clotting is triggered with cephalin, activator and calcium (APTT). FVIII:C is the limiting factor and clotting time is inversely proportional to the concentration of FVIII:
|SKU ID#||Packaging||Website Links|
|ADP040K-RUO||6 x 1 mL||www.clottingtesting.com |
|Assay Characteristics||Kit Components||Applications|
|Citrated human plasma, deficient for Factor VIII:C, immuno-depleted, lyophilized in the presence of glycine and stabilizers.||For measurement of Factor VIII:C (FVIII:C) activity in research applications. |
For any in vitro protocol or research study where a source of human FVIII:C deficient plasma is required.
Associated calibrator and controls are available: BIOPHEN Plasma Calibrator (Ref A222101-RUO), BIOPHEN Normal Control Plasma (Ref A223201-RUO) and BIOPHEN Abnormal Control Plasma (Ref A223301-RUO).
Please note: This product is intended for Research Use Only (RUO) in the US, and must bear this labeling per FDA regulations. Alternate CE Mark (IVD) labeling for use in countries outside the US is available below.
Streamline Laboratory ProceduresReady-to-use reagents and buffers, from Medicago AB. Available in tablets and pouches.
|Package Inserts||MSDS||Tech Specs||Adaptations|
|FVIII:C Deficient Plasma - RUO |
FVIII:C Deficient Plasma - CE
|FVIII:C Deficient Plasma||N/A||Request Adaptations|